Close
Smartlab Europe
Inizio Ignite

Drug Research

Innovative Partnership For RNA Medicine Delivery Solutions

The Centre for Process Innovation (CPI) plans to establish a new Intracellular Drug Delivery Centre in the UK to develop innovative lipid nanoparticle (LNP) formulations for delivering RNA-based medicines. This partnership, funded by a £10 million grant from Innovate...

Sterling Joins Partnership to Advance AI Flow Chemistry Techniques

Sterling Pharma Solutions will join a consortium of leading industrial innovators from across the chemical industry supply chain to accelerate the use of continuous manufacturing in a range of industries, with digitalization at its core. The partnership, expected to last...

ASM Research Chemicals Launches Development Packs for API Manufacturing

ASM Research Chemicals, a contract research and development services provider specialized in organic chemistry, is launching its new development pack (DevPack) service intended for active pharmaceutical ingredients (APIs) manufacturing. The service was developed and optimized across ten core partners to...

Watson-Marlow introduces KROHNE flowmeter to safeguard accuracy of fluid flow

Watson-Marlow Fluid Technology Solutions announces the company now offers the KROHNE FLEXMAG 4050 C ® electromagnetic flowmeter for biopharmaceutical customers. As a highly accurate and reliable flow measuring system that seamlessly integrates with other WMFTS products, it reinforces the company’s position as...

Updated Vaccine Composition Strategy To Tackle New Strains

A report has been published by international regulators that highlights the outcomes of the discussion they had pertaining to COVID-19 vaccines, as well as the need for and the strategy so as to update the composition based on evidence...

WHO & Republic of Korea Tie-Up For Biomanufacturing Training

The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a worldwide training hub when it comes to biomanufacturing. The worldwide training centre will go on...

China Fines Pharmaceutical Firms For Monopolistic Behaviour

Two pharmaceutical companies for monopolistic behaviour have been penalized by the Chinese regulator. It has put a fine on Grand Pharmaceuticals for 136 million yuan, which is equivalent to $19.68 million, and has also confiscated 149 million of revenue...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »